Patent: 4,864,020
✉ Email this page to a colleague
Summary for Patent: 4,864,020
Title: | Monoclonal antibodies and cell lines for parathyroid tissue-specific antigen parathyroid-specific |
Abstract: | Monoclonal antibodies specific for an antigen present on the surface of parathyroid tissue are useful in imaging such tissue when conjugated to suitable label. The antibodies of the invention bind exclusively to parathyroid surfaces and do not bind to other tissues. The antibodies are useful in establishing the location of the parathyroid whether in its normal location or in ectopic placements. An exemplary monoclonal has been deposited at the American Type Culture Collection and has accession number ATCC No. HB9917. |
Inventor(s): | Cance; William G. (St. Louis, MO), Davie; Joseph M. (St. Louis, MO), Wells, Jr.; Samuel A. (St. Louis, MO), Dilley; William G. (St. Louis, MO), Welch; Michael J. (St. Louis, MO), Morrissey, IV; Jeremiah J. (St. Louis, MO) |
Assignee: | Washington University School of Medicine (St. Louis, MO) |
Application Number: | 06/808,865 |
Patent Claims: | see list of patent claims |
Details for Patent 4,864,020
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |